References
- 1. Gonzalez RR, Kaplan SA. First-line treatment for symptomatic benign prostatic hyperplasia: is there a particular patient profile for a particular treatment? World J Urol. 2006; 24:360-6.10.1007/s00345-006-0092-0
- 2. Rosen RC. Assessment of sexual dysfunction in patients with benign prostatic hyperplasia. BJU Int. 2006; 97 Suppl 2:29-33; discussion 44-25.10.1111/j.1464-410X.2006.06103.x
- 3. Rosen RC, Giuliano F, Carson CC. Sexual dysfunction and lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). Eur Urol. 2005; 47:824-37.10.1016/j.eururo.2004.12.013
- 4. McNaughton-Collins M, Barry MJ. Managing patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Am J Med. 2005; 118: 1331-9.10.1016/j.amjmed.2004.12.033
- 5. Fitzpatrick JM. The natural history of benign prostatic hyperplasia. BJU Int. 2006; 97 Suppl 2:3-6; discussion 21-2.10.1111/j.1464-410X.2006.06097.x
- 6. Logan YT, Belgeri MT. Monotherapy versus combination drug therapy for the treatment of benign prostatic hyperplasia. Am J Geriatr Pharmacother. 2005; 3:103-14.10.1016/S1543-5946(05)00031-0
- 7. Milani S, Djavan B. Lower urinary tract symptoms suggestive of benign prostatic hyperplasia: latest update on alpha-adrenoceptor antagonists. BJU Int. 2005; 95 Suppl 4:29-36.10.1111/j.1464-410X.2005.05485.x
- 8. Sandhu JS, Vaughan ED, Jr. Combination therapy for the pharmacological management of benign prostatic hyperplasia: rationale and treatment options. Drugs Aging. 2005; 22:901-12.10.2165/00002512-200522110-00002
- 9. Martin DJ, Mulhall JP. Enlarging the scope of managing benign prostatic hyperplasia: addressing sexual function and quality of life. Int J Clin Pract. 2005; 59: 579-90.10.1111/j.1368-5031.2005.00531.x
- 10. Wilson LC, Gilling PJ. From coagulation to enucleation: the use of lasers in surgery for benign prostatic hyperplasia. Nat Clin Pract Urol. 2005; 2:443-8.10.1038/ncpuro0276
- 11. Alschibaja M, May F, Treiber U, Paul R, Hartung R. Recent improvements in transurethral high-frequency electrosurgery of the prostate. BJU Int. 2006; 97:243-6.10.1111/j.1464-410X.2006.05872.x
- 12. Rocco B, Albo G, Ferreira RC, Spinelli M, Cozzi G, Dell’orto P, et al. Recent advances in the surgical treatment of benign prostatic hyperplasia. Ther Adv Urol. 2011; 3:263-72.10.1177/1756287211426301
- 13. Wasson JH, Bubolz TA, Lu-Yao GL, Walker-Corkery E, Hammond CS, Barry MJ. Transurethral resection of the prostate among medicare beneficiaries: 1984 to 1997. For the Patient Outcomes Research Team for Prostatic Diseases. J Urol. 2000; 164:1212-5.
- 14. Hoffman RM, MacDonald R, Monga M, Wilt TJ. Transurethral microwave thermotherapy vs transurethral resection for treating benign prostatic hyperplasia: a systematic review. BJU Int. 2004; 94: 1031-6.10.1111/j.1464-410X.2004.05099.x
- 15. Hahn RG. Fluid absorption in endoscopic surgery. Br J Anaesth. 2006; 96:8-20.
- 16. Rassweiler J, Teber D, Kuntz R, Hofmann R. Complications of transurethral resection of the prostate (TURP)-incidence, management, and prevention. Eur Urol. 2006; 50:969-79; discussion 980.10.1016/j.eururo.2005.12.042
- 17. Glazener C, Boachie C, Buckley B, Cochran C, Dorey G, Grant A, et al. Urinary incontinence in men after formal one-to-one pelvic-floor muscle training following radical prostatectomy or transurethral resection of the prostate (MAPS): two parallel randomised controlled trials. Lancet. 2011; 378:328-37.10.1016/S0140-6736(11)60751-4
- 18. Hung CL, Wu CJ, Yang S, Chen HH, Lin JS. Acute renal failure directly caused by hemolysis associated with transurethral resection of the prostate. Urology. 2002; 59:137.10.1016/S0090-4295(01)01477-7
- 19. Nesbit RM, Glickman SI. The use of glycine solution as an irrigating medium during transurethral resection. J Urol. 1948; 59:1212-6.
- 20. Yousef AA, Suliman GA, Elashry OM, Elsharaby MD, Elgamasy Ael N. A randomized comparison between three types of irrigating fluids during transurethral resection in benign prostatic hyperplasia. BMC Anesthesiol. 2010; 10:7.
- 21. Collins JW, Macdermott S, Bradbrook RA, Keeley FX, Jr., Timoney AG. A comparison of the effect of 1.5% glycine and 5% glucose irrigants on plasma serum physiology and the incidence of transurethral resection syndrome during prostate resection. BJU Int. 2005; 96: 368-72.10.1111/j.1464-410X.2005.05633.x
- 22. Gupta K, Rastogi B, Jain M, Gupta PK, Sharma D. Electrolyte changes: An indirect method to assess irrigation fluid absorption complications during transurethral resection of prostate: A prospective study. Saudi J Anaesth. 2010; 4:142-6.
- 23. Hoekstra PT, Kahnoski R, McCamish MA, Bergen W, Heetderks DR. Transurethral prostatic resection syndrome-a new perspective: encephalopathy with associated hyperammonemia. J Urol. 1983; 130:704-7.
- 24. Hahn RG. Acid phosphatase levels in serum during transurethral prostatectomy. Br J Urol. 1989; 64:500-3.
- 25. Coppinger SW, Lewis CA, Milroy EJ. A method of measuring fluid balance during transurethral resection of the prostate. Br J Urol. 1995; 76:66-72.
- 26. Hahn RG, Ekengren JC. Patterns of irrigating fluid absorption during transurethral resection of the prostate as indicated by ethanol. J Urol. 1993; 149: 502-6.
- 27. Hulten JO, Tran VT, Pettersson G. The control of haemolysis during transurethral resection of the prostate when water is used for irrigation: monitoring absorption by the ethanol method. BJU Int. 2000; 86: 989-92.10.1046/j.1464-410x.2000.00979.x
- 28. Bender DA, Coppinger SW. Estimation of irrigant absorption during transurethral resection of the prostate. Assessment of fluorescein as a marker. Urol Res. 1992; 20:67-9.10.1007/BF00294340
- 29. Piros D, Fagerstrom T, Collins JW, Hahn RG. Glucose as a marker of fluid absorption in bipolar transurethral surgery. Anesth Analg. 2009; 109:1850-5.10.1213/ane.0b013e3181b0843b
- 30. Zhang W, Andersson BS, Hahn RG. Effect of irrigating fluids and prostate tissue extracts on isolated cardiomyocytes. Urology. 1995; 46:821-4.10.1016/S0090-4295(99)80351-3
- 31. Lee GY, Han JI, Heo HJ. Severe hypocalcemia caused by absorption of sorbitol-mannitol solution during hysteroscopy. J Korean Med Sci. 2009; 24:532-4.10.3346/jkms.2009.24.3.532
- 32. Chen SS, Lin AT, Chen KK, Chang LS. Hemolysis in transurethral resection of the prostate using distilled water as the irrigant. J Chin Med Assoc. 2006; 69: 270-5.10.1016/S1726-4901(09)70255-2
- 33. Moharari RS, Khajavi MR, Khademhosseini P, Hosseini SR, Najafi A. Sterile water as an irrigating fluid for transurethral resection of the prostate: anesthetical view of the records of 1600 cases. South Med J. 2008; 101:373-5.10.1097/SMJ.0b013e318167ddae
- 34. Gravenstein D. Transurethral resection of the prostate (TURP) syndrome: a review of the pathophysiology and management. Anesth Analg. 1997; 84:438-46.10.1213/00000539-199702000-00037
- 35. Issa MM, Young MR, Bullock AR, Bouet R, Petros JA. Dilutional hyponatremia of TURP syndrome: a historical event in the 21st century. Urology. 2004; 64: 298-301.10.1016/j.urology.2004.03.023
- 36. Starkman JS, Santucci RA. Comparison of bipolar transurethral resection of the prostate with standard transurethral prostatectomy: shorter stay, earlier catheter removal and fewer complications. BJU Int. 2005; 95:69-71.10.1111/j.1464-410X.2005.05253.x
- 37. Aghamir SM, Alizadeh F, Meysamie A, Assefi Rad S, Edrisi L. Sterile water versus isotonic saline solution as irrigation fluid in percutaneous nephrolithotomy. Urol J. 2009; 6:249-53. 368-72.